It is a questionable disease in the field of genetic metabolism and clinical performance is complex and often involves multi-systematic stress. Early identification and standardised clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic diseases have been significantly improved. Treatment requires close monitoring of therapeutic effects and adverse reactions and timely adjustment to changes in the course of the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of adults with carcinoma deficiency. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.